The content of this website is intended for United States audiences only.
LAST UPDATED
March 26 2025
Clinicaltrials.gov ID
CTSID
CTSID
A Phase 3 Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Follicular Lymphoma (ZUMA-22)
The goal of this clinical study is test how well the study drug, axicabtagene ciloleucel, works in participants with relapsed/refractory follicular lymphoma
View MoreAge
18 Years +
Sex
ALL
Healthy Volunteers
No
Medical Condition
Relapsed/Refractory Follicular Lymphoma
Gender
N/A
Date
September 2022 - October 2030
Study Type
INTERVENTIONAL
Study Phase
PHASE3
Product
Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine, Lenalidomide, Rituximab, Doxorubicin, Vincristine, Prednisone, Bendamustine
Little Rock, Arkansas, United States, 72205
Duarte, California, United States, 91010
Orange, California, United States, 92868
Stanford, California, United States, 94305
Denver, Colorado, United States, 80218
Washington, District of Columbia, United States, 20007
Tampa, Florida, United States, 33612
Westwood, Kansas, United States, 66205
Lexington, Kentucky, United States, 40536
Baltimore, Maryland, United States, 21201
Boston, Massachusetts, United States, 02215
Hackensack, New Jersey, United States, 07601
New York, New York, United States, 10032
Charlotte, North Carolina, United States, 28204
Cincinnati, Ohio, United States, 45242
Hershey, Pennsylvania, United States, 17033
Pittsburgh, Pennsylvania, United States, 15232
Greenville, South Carolina, United States, 29615
Sioux Falls, South Dakota, United States, 57105
Nashville, Tennessee, United States, 37203
Nashville, Tennessee, United States, 37232
Houston, Texas, United States, 77030
Norfolk, Virginia, United States, 23502
Richmond, Virginia, United States, 23298
Créteil, France, 94010
Dijon, France, 21079
Lille cedex, France, 59037
Marseille, France, 13273
Montpellier, France, 34295
Paris, France, 75013
Pessac, France, 33604
Pierre Benite, France, 69495
Poitiers, France, 86021
Rennes, France, 35033
Rouen, France, 76038
Berlin, Germany, 13125
Cologne, Germany, 50937
Göttingen, Germany, 37075
Leipzig, Germany, 4103
Ulm, Germany, 89081
Wuerzburg, Germany, 97080
Bergamo, Italy, 24128
Bologna, Italy, 40138
Genova, Italy, 16132
Milano, Italy, 20100
Milano, Italy, 20132
Reggio Emilia, Italy, 42123
Rozzano, Italy, 20089
Hyogo, Japan, 663-8501
Kyoto, Japan, 602-8566,
Miyagi, Japan, 980-8574
Okayama, Japan, 700-8558
Osaka, Japan, 565-0871
Barcelona, Spain, 08035
Barcelona, Spain, 08036
Barcelona, Spain, 08908
Madrid, Spain, 28009
Madrid, Spain, 28041
Salamanca, Spain, 37007
Sevilla, Spain, 41013
Valencia, Spain, 46010
Birmingham, United Kingdom, B15 2GW
Cambridge, United Kingdom, CB2 2QQ
London, United Kingdom, NW2 2QG
London, United Kingdom, SE5 9RS
Manchester, United Kingdom, M20 4BX
Oxford, United Kingdom, OX3 7LE
Southampton, United Kingdom, SO16 6YD
Sutton, United Kingdom, SM2 5PT
Share Trial